Cargando…
An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile
We analyze the patent filing strategies of foreign pharmaceutical companies in Chile distinguishing between “primary” (active ingredient) and “secondary” patents (patents on modified compounds, formulations, dosages, particular medical uses, etc.). There is prior evidence that secondary patents are...
Autores principales: | Abud, María José, Hall, Bronwyn, Helmers, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411059/ https://www.ncbi.nlm.nih.gov/pubmed/25915050 http://dx.doi.org/10.1371/journal.pone.0124257 |
Ejemplares similares
-
Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of “Secondary” Pharmaceutical Patents
por: Kapczynski, Amy, et al.
Publicado: (2012) -
Empirical prediction of patent pledge financing of pharmaceutical enterprises—A case study in Jiangsu China
por: Zhao, Xiaojuan, et al.
Publicado: (2020) -
Pharmaceutical antitrust enforcement in the United States and Chile
por: Carrier, Michael A, et al.
Publicado: (2021) -
Pharmaceutical patenting in the European Union: reform or riddance
por: Garattini, Livio, et al.
Publicado: (2021) -
Automating the search for a patent’s prior art with a full text similarity search
por: Helmers, Lea, et al.
Publicado: (2019)